文献
J-GLOBAL ID:202202286250426510
整理番号:22A0451111
再発性/難治性末梢性T細胞リンパ腫におけるカルフィルゾミブの第1相試験【JST・京大機械翻訳】
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
著者 (10件):
Krishnan Mridula
(Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA)
,
Bociek R. Gregory
(Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA)
,
Fanale Michelle
(Department of Lymphoma/Multiple Myeloma, MD Anderson Cancer Center, Houston, TX, USA)
,
Iyer Swaminathan P.
(Department of Lymphoma/Multiple Myeloma, MD Anderson Cancer Center, Houston, TX, USA)
,
Lechowicz Mary Jo
(Department of Hematology, Emory University, Atlanta, GA, USA)
,
Bierman Philip J.
(Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA)
,
Armitage James O.
(Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA)
,
Lunning Matthew
(Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA)
,
Kallam Avyakta
(Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA)
,
Vose Julie M.
(Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA)
資料名:
Annals of Hematology
(Annals of Hematology)
巻:
101
号:
2
ページ:
335-340
発行年:
2022年
JST資料番号:
W4037A
ISSN:
0939-5555
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)